Lifetime risk of malignancy in polymyalgia rheumatica: a population-based matched cohort study from southern Norway
OBJECTIVES: Prior studies examining the malignancy risk in polymyalgia rheumatica (PMR) have reported conflicting results, with some indicating an increased risk within 6-12 months after diagnosis. This study assessed malignancy risk over the lifetime and at different follow-up…